-
Loading metrics
Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab
- C. L. Kemmerer ,
- V. Pernpeintner ,
- C. Ruschil,
- A. Abdelhak,
- M. Scholl,
- U. Ziemann,
- M. Krumbholz,
- B. Hemmer,
-
M. C. Kowarik
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Supervision, Writing – review & editing
* E-mail: markus.kowarik@uni-tuebingen.de
Affiliations Department of Neurology & Stroke, and Hertie-Institute for Clinical Brain Research, Eberhard-Karls University of Tübingen, Tübingen, Germany, Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
⨯
http://orcid.org/0000-0003-1389-5539
Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab
- C. L. Kemmerer,
- V. Pernpeintner,
- C. Ruschil,
- A. Abdelhak,
- M. Scholl,
- U. Ziemann,
- M. Krumbholz,
- B. Hemmer,
- M. C. Kowarik
x
- Published: July 27, 2020
- https://doi.org/10.1371/journal.pone.0235449